Nizatidine Oral Solution, 15 mg/mL (75 mg/5mL) USP 480 mL bottles, Rx Only Distributed by: Gemini Laboratories, LLC Bridgewater, NJ 08807 NDC 60846-301-15
Published May 6, 2020 · Recall initiated: April 15, 2020
Summary
FDA records drug Class II recall D-1253-2020, published May 6, 2020 and initiated April 15, 2020. Recalling firm: Amneal Pharmaceuticals of New York, LLC; Status: Terminated; Reported quantity: 11258 bottles; Lot: 06598004A 04/2020 06599001A 12/2020 06599002A 12/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.
What to do
Voluntary: Firm initiated · Press Release
Get an email if NIZATIDINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- NIZATIDINE
- Manufacturer
- Amneal Pharmaceuticals of New York, LLC
- Distributor
- Nationwide
- Lot
- 06598004A 04/2020 06599001A 12/2020 06599002A 12/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEsomeprazole Magnesium Delayed Release Capsules USP, 40 mg*, 1000-count bottles, Rx only, Mfd. By: Dr. Reddy'sMay 6, 2020
- FDACeftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B BraunMay 6, 2020
- FDAXinXing Dried Plum, Net Wt. 5.3 oz.(150g)May 6, 2020
- FDATemperature Sensing 100% Silicone Foley Catheter, Part Number 102201101063MD - Product Usage: is a 3 lumenApril 29, 2020
- FDATemperature Sensing 100% Silicone Foley Catheter, Part Number 102201100880MD - Product Usage: is a 3 lumenApril 29, 2020
- FDAMedivators Endo carry-on Procedure Kit REF CPK-100222-0002 - Product Usage: is intended to be used with an airApril 29, 2020
Questions about this recall
Was Nizatidine Oral Solution, 15 mg/mL (75 mg/5mL) USP 480 mL bottles, Rx Only Distributed by: Gemini Laboratories, LLC Bridgewater, NJ 08807 NDC 60846-301-15 recalled?
Yes. FDA published recall D-1253-2020 on May 6, 2020. Reported hazard: CGMP Deviations: potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: NIZATIDINE.